Search Results - "Sande, Luis Miguel de"
-
1
Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study
Published in BMC cancer (05-07-2024)“…Trabectedin in combination with pegylated liposomal doxorubicin (PLD) is approved for the treatment of patients with platinum-sensitive relapsed ovarian…”
Get full text
Journal Article -
2
A Growth Modulation Index-Based GEISTRA Score as a New Prognostic Tool for Trabectedin Efficacy in Patients with Advanced Soft Tissue Sarcomas: A Spanish Group for Sarcoma Research (GEIS) Retrospective Study
Published in Cancers (14-02-2021)“…The aim of this study was to identify an easily reliable prognostic score that selects the subset of advanced soft tissue sarcoma (ASTS) patients with a higher…”
Get full text
Journal Article -
3
Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor
Published in European journal of cancer (1990) (01-09-2024)“…Prognostic biomarkers remain necessary in sporadic desmoid tumor (DT) because the clinical course is unpredictable. DT location along with gene expression…”
Get full text
Journal Article -
4
The Scarface Score: Deciphering Response to DNA Damage Agents in High-Grade Serous Ovarian Cancer-A GEICO Study
Published in Cancers (01-06-2023)“…Genomic Instability (GI) is a transversal phenomenon shared by several tumor types that provide both prognostic and predictive information. In the context of…”
Get full text
Journal Article -
5
Real-world evidence of the efficacy and tolerability of trabectedin in patients with advanced soft-tissue sarcoma
Published in Expert review of anticancer therapy (01-11-2020)“…The efficacy and tolerability of trabectedin in patients with soft tissue sarcoma (STS) have been confirmed by various clinical studies involving lipo- and…”
Get full text
Journal Article -
6
A European, Observational, Prospective Trial of Trabectedin Plus Pegylated Liposomal Doxorubicin in Patients with Platinum‐Sensitive Ovarian Cancer
Published in The oncologist (Dayton, Ohio) (01-04-2021)“…Purpose The noninterventional, prospective NIMES‐ROC phase IV study (NCT02825420) evaluated trabectedin plus pegylated liposomal doxorubicin (PLD) in real‐life…”
Get full text
Journal Article -
7
Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin
Published in BMC cancer (05-07-2024)“…Background Trabectedin in combination with pegylated liposomal doxorubicin (PLD) is approved for the treatment of patients with platinum-sensitive relapsed…”
Get full text
Journal Article -
8
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial
Published in Journal of clinical oncology (18-09-2024)“…To evaluate atezolizumab combined with platinum-based chemotherapy (CT) followed by maintenance niraparib for late-relapsing recurrent ovarian cancer. The…”
Get full text
Journal Article -
9
P-184 Data from the Cetuximab-Docetaxel scheme in head and neck cancer in patients with intermediate general condition in daily clinical practice
Published in Oral oncology (01-07-2021)Get full text
Journal Article -
10
Prognostic role of HMG proteins in a series of 301 advanced soft tissue sarcoma patients: A Spanish Group for Sarcoma Research Study (GEIS)
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
11
Prognostic relevance of miRNA let-7e in localized intestinal GIST: A Spanish Group for Research on Sarcoma (GEIS) Study
Published in Journal of clinical oncology (20-05-2015)“…Abstract only…”
Get full text
Journal Article -
12
Immune-checkpoint genes as predictive biomarkers of trabectedin in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) translational study
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 11546 Background: Despite several second-line options are accessible for the treatment of advanced STS, there is a lack of predictive biomarkers…”
Get full text
Journal Article -
13
Prognostic significance of Wnt signaling pathway molecules in nongastric GIST patients: A tissue microarray-based (TMA) analysis
Published in Journal of clinical oncology (20-05-2013)“…Abstract only 10529 Background: Pathogenesis in GIST could be related to cancer stem cell hypothesis (highly chemo resistant, very uncommon complete responses,…”
Get full text
Journal Article -
14
MicroRNA profiling analysis in a series of high-risk intestinal GISTs
Published in Journal of clinical oncology (20-05-2013)“…Abstract only 10532 Background: Resected localized GISTs exhibit a wide range of biological behavior from low to high risk of recurrence. Risk categories (low,…”
Get full text
Journal Article